GED-0507-34-Levo 80 mg ( DrugBank: GED-0507-34-Levo )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
97潰瘍性大腸炎2

97. 潰瘍性大腸炎


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02808390
(ClinicalTrials.gov)
November 28, 201614/6/2016Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UCA Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of GED-0507-34-Levo (GED0507) for Treatment of Subjects With Active Ulcerative ColitisUlcerative ColitisDrug: GED-0507-34-Levo 80 mg;Drug: GED-0507-34-Levo 160 mg;Drug: PlaceboPPM Services S.A.NULLTerminated18 YearsN/AAll19Phase 2United States;Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Ukraine
2EUCTR2011-003283-78-IT
(EUCTR)
09/01/201201/03/2012A PROOF-OF-CONCEPT CLINICAL STUDY, TO ASSESS THE EFFECT OF GED-0507-34-Levo 80 mg Tablets IN INDUCTION OF REMISSION OF ACTIVE ULCERATIVE COLITISA PROOF-OF-CONCEPT CLINICAL STUDY, TO ASSESS THE EFFECT OF GED-0507-34-Levo 80 mg Tablets IN INDUCTION OF REMISSION OF ACTIVE ULCERATIVE COLITIS Active Ulcerative Colitis Patients
MedDRA version: 14.1;Level: LLT;Classification code 10021184;Term: IBD;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: NA
Product Code: GED-0507-34-Levo
INN or Proposed INN: (-)-3-(4-Aminophenyl)-2-methoxypropionic acid
Other descriptive name: NA
GIULIANINULLNot RecruitingFemale: yes
Male: yes
Italy